Growing Global Nicotine Pouch Market Predicted to Reach $23.6 Billion by 2030

Market by 2FIRSTS.ai
Jan.29.2024
Growing Global Nicotine Pouch Market Predicted to Reach $23.6 Billion by 2030
Global nicotine pouch market is predicted to reach almost $23.6 billion by 2030, with a staggering 35.8% CAGR between 2024 and 2030, driven by increasing demand for smokeless tobacco alternatives.

According to a report released by market research and consulting firm Maximize Market Research Pvt Ltd on January 29, the global nicotine pouch market is predicted to experience substantial growth, with an estimated market value reaching nearly $23.6 billion by 2030. This market forecast suggests that the industry will maintain an impressive compound annual growth rate of 35.8% during the period from 2024 to 2030.

 

The rapid growth of the global nicotine pouch market is primarily driven by the increasing demand for smokeless and tobacco-free alternatives. Strengthened smoking regulations and improved awareness of the negative effects of traditional tobacco products have prompted consumers to further prefer smokeless alternatives, portability, and discreet usage, thereby stimulating market expansion.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Dutch doctors accuse Snapchat of not implementing its ban commitment, with e-cigarette transactions still rampant
Dutch doctors accuse Snapchat of not implementing its ban commitment, with e-cigarette transactions still rampant
In June 2025, the instant messaging app Snapchat promised to take measures to prevent minors from being exposed to illegal e-cigarette transactions through the platform. However, an investigation by doctors from the Leiden University Medical Center in the Netherlands found that the number of e-cigarette sellers not only failed to decrease after the promise but actually increased from 607 to 615. Purchasing remains just as easy.
Aug.28 by 2FIRSTS.ai
U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement
U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement
The U.S. Bankruptcy Court in New York has approved and recognized the restructuring plan of Imperial Tobacco Canada Ltd., granting legal effect in the U.S. to its participation in a CA$32.5 billion (US$23.6 billion) tobacco litigation settlement. The case is considered one of the largest corporate restructurings in Canadian history and also involves Japan Tobacco International (JTI), Philip Morris International (PMI), and British American Tobacco (BAT).
Aug.28 by 2FIRSTS.ai
Singapore's Woodlands Checkpoint Seizes Over 5,900 Vaping Products; Case Referred for Investigation
Singapore's Woodlands Checkpoint Seizes Over 5,900 Vaping Products; Case Referred for Investigation
On July 24, Singapore’s Immigration & Checkpoints Authority (ICA) conducted an enhanced inspection of a Malaysia-registered vehicle at Woodlands Checkpoint and uncovered more than 5,900 e-cigarettes and related components, along with 150 heat-not-burn tobacco sticks concealed in multiple compartments. The case has been handed over to the Health Sciences Authority for further investigation, thwarting the smuggling attempt.
Aug.06 by 2FIRSTS.ai
Observation | Clear Tank E-Cigs Surge: Dedicated Coils Emerge as Supply Chain Best-Sellers
Observation | Clear Tank E-Cigs Surge: Dedicated Coils Emerge as Supply Chain Best-Sellers
At the e-cigarette supply chain expo held in Shenzhen on August 26, 2Firsts learned that dedicated coils for clear tank e-cigarettes have emerged as the top-selling products among suppliers.
Aug.26 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Singapore arrests 195 in nationwide crackdown on e-cigarette violations, seizes dangerous 'Kpods' containing anesthesia substance
Singapore arrests 195 in nationwide crackdown on e-cigarette violations, seizes dangerous 'Kpods' containing anesthesia substance
Singapore recently launched a nationwide operation, arresting 195 individuals for e-cigarette violations and uncovering “Kpods” e-cigarettes containing dangerous substances, which has raised health concerns.
Sep.01 by 2FIRSTS.ai